Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
18
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Hailey James R | SVP & Pres-Pharmacy Operations | 11 | $0 | $0 | 2012-01-31 |
| Fox John T | Director | 1 | $0 | $0 | 2012-01-31 |
| Mirt Michael G | President | 9 | $0 | $0 | 2012-01-31 |
| Wales Dirk O | SVP ? Chief Medical Officer | 10 | $0 | $0 | 2012-01-31 |
| Leon Benjamin JR | Director | 1 | $0 | $0 | 2012-01-31 |
| Mansukani Sharad | Director | 4 | $0 | $0 | 2012-01-31 |
| Huebner Scott C | EVP | 10 | $0 | $0 | 2012-01-31 |
| Morris Matthew Shawn | EVP | 10 | $0 | $0 | 2012-01-31 |
| Tulloch Mark A | EVP and COO | 12 | $0 | $0 | 2012-01-31 |
| Barden J Gentry | Senior VP, Gen Counsel & Sec | 9 | $0 | $0 | 2012-01-31 |
| Terry David L Jr | Senior VP & Chief Actuary | 10 | $0 | $0 | 2012-01-31 |
| Fritch Herbert A | Chairman & CEO | 8 | $0 | $0 | 2012-01-31 |
| Hensley Robert Z | Director | 1 | $0 | $0 | 2012-01-31 |
| MAYERFELD RUSSELL K | Director | 1 | $0 | $0 | 2012-01-31 |
| FRIED BRUCE M | Director | 1 | $0 | $0 | 2012-01-31 |
| FOLICK JEFFREY | Director | 1 | $0 | $0 | 2012-01-31 |
| WITTY KAREY L | Exec VP and CFO | 9 | $0 | $0 | 2012-01-31 |
| NOLAN JOSEPH P | Director | 1 | $0 | $0 | 2012-01-31 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Morris Matthew Shawn | EVP | D To issuer deriv | 2012-01-31 | 2012-02-01 | 7,252 | — | $0 | 0 | SEC↗ |
| Morris Matthew Shawn | EVP | D To issuer deriv | 2012-01-31 | 2012-02-01 | 6,181 | — | $0 | 0 | SEC↗ |
| Morris Matthew Shawn | EVP | D To issuer deriv | 2012-01-31 | 2012-02-01 | 14,324 | — | $0 | 0 | SEC↗ |
| Huebner Scott C | EVP | D To issuer deriv | 2012-01-31 | 2012-02-01 | 6,181 | — | $0 | 0 | SEC↗ |
| Huebner Scott C | EVP | D To issuer deriv | 2012-01-31 | 2012-02-01 | 14,324 | — | $0 | 0 | SEC↗ |
| Huebner Scott C | EVP | D To issuer deriv | 2012-01-31 | 2012-02-01 | 17,252 | — | $0 | 0 | SEC↗ |
| Huebner Scott C | EVP | D To issuer deriv | 2012-01-31 | 2012-02-01 | 100,000 | — | $0 | 0 | SEC↗ |
| Tulloch Mark A | EVP and COO | D To issuer deriv | 2012-01-31 | 2012-02-01 | 4,313 | — | $0 | 0 | SEC↗ |
| Tulloch Mark A | EVP and COO | D To issuer deriv | 2012-01-31 | 2012-02-01 | 6,181 | — | $0 | 0 | SEC↗ |
| Tulloch Mark A | EVP and COO | D To issuer deriv | 2012-01-31 | 2012-02-01 | 7,162 | — | $0 | 0 | SEC↗ |
| Mansukani Sharad | Director | D To issuer deriv | 2012-01-31 | 2012-02-01 | 4,121 | — | $0 | 0 | SEC↗ |
| Mansukani Sharad | Director | D To issuer deriv | 2012-01-31 | 2012-02-01 | 50,000 | — | $0 | 0 | SEC↗ |
| Mansukani Sharad | Director | D To issuer deriv | 2012-01-31 | 2012-02-01 | 1,164 | — | $0 | 0 | SEC↗ |
| Terry David L Jr | Senior VP & Chief Actuary | D To issuer deriv | 2012-01-31 | 2012-02-01 | 6,181 | — | $0 | 0 | SEC↗ |
| Terry David L Jr | Senior VP & Chief Actuary | D To issuer deriv | 2012-01-31 | 2012-02-01 | 7,162 | — | $0 | 0 | SEC↗ |
| Terry David L Jr | Senior VP & Chief Actuary | D To issuer deriv | 2012-01-31 | 2012-02-01 | 4,313 | — | $0 | 0 | SEC↗ |
| WITTY KAREY L | Exec VP and CFO | D To issuer deriv | 2012-01-31 | 2012-02-01 | 82,418 | — | $0 | 0 | SEC↗ |
| WITTY KAREY L | Exec VP and CFO | D To issuer deriv | 2012-01-31 | 2012-02-01 | 116,000 | — | $0 | 0 | SEC↗ |
| Mirt Michael G | President | D To issuer deriv | 2012-01-31 | 2012-02-01 | 160,000 | — | $0 | 0 | SEC↗ |
| Mirt Michael G | President | D To issuer deriv | 2012-01-31 | 2012-02-01 | 113,324 | — | $0 | 0 | SEC↗ |
| Hailey James R | SVP & Pres-Pharmacy Operatio | D To issuer deriv | 2012-01-31 | 2012-02-01 | 12,500 | — | $0 | 0 | SEC↗ |
| Hailey James R | SVP & Pres-Pharmacy Operatio | D To issuer deriv | 2012-01-31 | 2012-02-01 | 6,181 | — | $0 | 0 | SEC↗ |
| Barden J Gentry | Senior VP, Gen Counsel & Sec | D To issuer deriv | 2012-01-31 | 2012-02-01 | 17,252 | — | $0 | 0 | SEC↗ |
| Barden J Gentry | Senior VP, Gen Counsel & Sec | D To issuer deriv | 2012-01-31 | 2012-02-01 | 6,181 | — | $0 | 0 | SEC↗ |
| Barden J Gentry | Senior VP, Gen Counsel & Sec | D To issuer deriv | 2012-01-31 | 2012-02-01 | 14,324 | — | $0 | 0 | SEC↗ |
| Wales Dirk O | SVP ? Chief Medical Officer | D To issuer deriv | 2012-01-31 | 2012-02-01 | 17,252 | — | $0 | 0 | SEC↗ |
| Fritch Herbert A | Chairman & CEO | D To issuer deriv | 2012-01-31 | 2012-02-01 | 72,697 | — | $0 | 0 | SEC↗ |
| Fritch Herbert A | Chairman & CEO | A Award deriv | 2012-01-31 | 2012-02-01 | 72,697 | — | $0 | 72,697 | SEC↗ |
| Fritch Herbert A | Chairman & CEO | D To issuer deriv | 2012-01-31 | 2012-02-01 | 72,697 | — | $0 | 0 | SEC↗ |
| Fritch Herbert A | Chairman & CEO | D To issuer deriv | 2012-01-31 | 2012-02-01 | 280,220 | — | $0 | 0 | SEC↗ |
| Fritch Herbert A | Chairman & CEO | D To issuer deriv | 2012-01-31 | 2012-02-01 | 127,321 | — | $0 | 0 | SEC↗ |
| Fox John T | Director | D To issuer | 2012-01-31 | 2012-02-01 | 8,285 | — | $0 | 0 | SEC↗ |
| FOLICK JEFFREY | Director | D To issuer | 2012-01-31 | 2012-02-01 | 7,514 | — | $0 | 0 | SEC↗ |
| FRIED BRUCE M | Director | D To issuer | 2012-01-31 | 2012-02-01 | 26,985 | — | $0 | 0 | SEC↗ |
| Hensley Robert Z | Director | D To issuer | 2012-01-31 | 2012-02-01 | 31,735 | — | $0 | 0 | SEC↗ |
| Leon Benjamin JR | Director | D To issuer | 2012-01-31 | 2012-02-01 | 302,027 | — | $0 | 0 | SEC↗ |
| MAYERFELD RUSSELL K | Director | D To issuer | 2012-01-31 | 2012-02-01 | 35,168 | — | $0 | 0 | SEC↗ |
| NOLAN JOSEPH P | Director | D To issuer | 2012-01-31 | 2012-02-01 | 33,314 | — | $0 | 0 | SEC↗ |
| Morris Matthew Shawn | EVP | D To issuer | 2012-01-31 | 2012-02-01 | 4,152 | — | $0 | 0 | SEC↗ |
| Morris Matthew Shawn | EVP | D To issuer | 2012-01-31 | 2012-02-01 | 13,681 | — | $0 | 0 | SEC↗ |
| Morris Matthew Shawn | EVP | D To issuer | 2012-01-31 | 2012-02-01 | 25,000 | — | $0 | 0 | SEC↗ |
| Morris Matthew Shawn | EVP | D To issuer | 2012-01-31 | 2012-02-01 | 1,592 | — | $0 | 0 | SEC↗ |
| Morris Matthew Shawn | EVP | D To issuer | 2012-01-31 | 2012-02-01 | 485 | — | $0 | 0 | SEC↗ |
| Morris Matthew Shawn | EVP | D To issuer | 2012-01-31 | 2012-02-01 | 11,269 | — | $0 | 44,910 | SEC↗ |
| Huebner Scott C | EVP | D To issuer | 2012-01-31 | 2012-02-01 | 1,592 | — | $0 | 0 | SEC↗ |
| Huebner Scott C | EVP | D To issuer | 2012-01-31 | 2012-02-01 | 2,151 | — | $0 | 47,410 | SEC↗ |
| Huebner Scott C | EVP | D To issuer | 2012-01-31 | 2012-02-01 | 25,000 | — | $0 | 0 | SEC↗ |
| Huebner Scott C | EVP | D To issuer | 2012-01-31 | 2012-02-01 | 16,181 | — | $0 | 0 | SEC↗ |
| Huebner Scott C | EVP | D To issuer | 2012-01-31 | 2012-02-01 | 4,152 | — | $0 | 0 | SEC↗ |
| Huebner Scott C | EVP | D To issuer | 2012-01-31 | 2012-02-01 | 485 | — | $0 | 0 | SEC↗ |
| Tulloch Mark A | EVP and COO | A Award | 2012-01-31 | 2012-02-01 | 1,759 | — | $0 | 1,759 | SEC↗ |
| Tulloch Mark A | EVP and COO | D To issuer | 2012-01-31 | 2012-02-01 | 8,990 | — | $0 | 44,503 | SEC↗ |
| Tulloch Mark A | EVP and COO | D To issuer | 2012-01-31 | 2012-02-01 | 485 | — | $0 | 0 | SEC↗ |
| Tulloch Mark A | EVP and COO | D To issuer | 2012-01-31 | 2012-02-01 | 1,592 | — | $0 | 0 | SEC↗ |
| Tulloch Mark A | EVP and COO | D To issuer | 2012-01-31 | 2012-02-01 | 13,681 | — | $0 | 0 | SEC↗ |
| Tulloch Mark A | EVP and COO | D To issuer | 2012-01-31 | 2012-02-01 | 1,759 | — | $0 | 0 | SEC↗ |
| Tulloch Mark A | EVP and COO | D To issuer | 2012-01-31 | 2012-02-01 | 3,745 | — | $0 | 0 | SEC↗ |
| Tulloch Mark A | EVP and COO | D To issuer | 2012-01-31 | 2012-02-01 | 25,000 | — | $0 | 0 | SEC↗ |
| Mansukani Sharad | Director | D To issuer | 2012-01-31 | 2012-02-01 | 21,188 | — | $0 | 0 | SEC↗ |
| Terry David L Jr | Senior VP & Chief Actuary | D To issuer | 2012-01-31 | 2012-02-01 | 13,681 | — | $0 | 0 | SEC↗ |
| Terry David L Jr | Senior VP & Chief Actuary | D To issuer | 2012-01-31 | 2012-02-01 | 1,592 | — | $0 | 0 | SEC↗ |
| Terry David L Jr | Senior VP & Chief Actuary | D To issuer | 2012-01-31 | 2012-02-01 | 3,606 | — | $0 | 0 | SEC↗ |
| Terry David L Jr | Senior VP & Chief Actuary | D To issuer | 2012-01-31 | 2012-02-01 | 485 | — | $0 | 0 | SEC↗ |
| Terry David L Jr | Senior VP & Chief Actuary | A Award | 2012-01-31 | 2012-02-01 | 1,739 | — | $0 | 1,739 | SEC↗ |
| Terry David L Jr | Senior VP & Chief Actuary | D To issuer | 2012-01-31 | 2012-02-01 | 79,802 | — | $0 | 19,364 | SEC↗ |
| Terry David L Jr | Senior VP & Chief Actuary | D To issuer | 2012-01-31 | 2012-02-01 | 1,739 | — | $0 | 0 | SEC↗ |
| WITTY KAREY L | Exec VP and CFO | D To issuer | 2012-01-31 | 2012-02-01 | 15,323 | — | $0 | 26,429 | SEC↗ |
| WITTY KAREY L | Exec VP and CFO | D To issuer | 2012-01-31 | 2012-02-01 | 7,127 | — | $0 | 0 | SEC↗ |
| WITTY KAREY L | Exec VP and CFO | A Award | 2012-01-31 | 2012-02-01 | 7,127 | — | $0 | 7,127 | SEC↗ |
| WITTY KAREY L | Exec VP and CFO | D To issuer | 2012-01-31 | 2012-02-01 | 5,000 | — | $0 | 0 | SEC↗ |
| WITTY KAREY L | Exec VP and CFO | D To issuer | 2012-01-31 | 2012-02-01 | 7,127 | — | $0 | 0 | SEC↗ |
| WITTY KAREY L | Exec VP and CFO | D To issuer | 2012-01-31 | 2012-02-01 | 14,302 | — | $0 | 0 | SEC↗ |
| Mirt Michael G | President | D To issuer | 2012-01-31 | 2012-02-01 | 9,800 | — | $0 | 0 | SEC↗ |
| Mirt Michael G | President | D To issuer | 2012-01-31 | 2012-02-01 | 21,176 | — | $0 | 34,465 | SEC↗ |
| Mirt Michael G | President | D To issuer | 2012-01-31 | 2012-02-01 | 9,800 | — | $0 | 0 | SEC↗ |
| Mirt Michael G | President | A Award | 2012-01-31 | 2012-02-01 | 9,800 | — | $0 | 9,800 | SEC↗ |
| Mirt Michael G | President | D To issuer | 2012-01-31 | 2012-02-01 | 19,665 | — | $0 | 0 | SEC↗ |
| Mirt Michael G | President | D To issuer | 2012-01-31 | 2012-02-01 | 5,000 | — | $0 | 0 | SEC↗ |
| Hailey James R | SVP & Pres-Pharmacy Operatio | A Award | 2012-01-31 | 2012-02-01 | 1,868 | — | $0 | 1,868 | SEC↗ |
| Hailey James R | SVP & Pres-Pharmacy Operatio | D To issuer | 2012-01-31 | 2012-02-01 | 6,160 | — | $0 | 17,112 | SEC↗ |
| Hailey James R | SVP & Pres-Pharmacy Operatio | D To issuer | 2012-01-31 | 2012-02-01 | 1,250 | — | $0 | 0 | SEC↗ |
| Hailey James R | SVP & Pres-Pharmacy Operatio | D To issuer | 2012-01-31 | 2012-02-01 | 1,868 | — | $0 | 0 | SEC↗ |
| Hailey James R | SVP & Pres-Pharmacy Operatio | D To issuer | 2012-01-31 | 2012-02-01 | 1,826 | — | $0 | 0 | SEC↗ |
| Hailey James R | SVP & Pres-Pharmacy Operatio | D To issuer | 2012-01-31 | 2012-02-01 | 3,855 | — | $0 | 0 | SEC↗ |
| Hailey James R | SVP & Pres-Pharmacy Operatio | D To issuer | 2012-01-31 | 2012-02-01 | 10,181 | — | $0 | 0 | SEC↗ |
| Barden J Gentry | Senior VP, Gen Counsel & Sec | D To issuer | 2012-01-31 | 2012-02-01 | 21,373 | — | $0 | 17,088 | SEC↗ |
| Barden J Gentry | Senior VP, Gen Counsel & Sec | D To issuer | 2012-01-31 | 2012-02-01 | 13,681 | — | $0 | 0 | SEC↗ |
| Barden J Gentry | Senior VP, Gen Counsel & Sec | D To issuer | 2012-01-31 | 2012-02-01 | 3,407 | — | $0 | 0 | SEC↗ |
| Barden J Gentry | Senior VP, Gen Counsel & Sec | A Award | 2012-01-31 | 2012-02-01 | 1,739 | — | $0 | 1,739 | SEC↗ |
| Barden J Gentry | Senior VP, Gen Counsel & Sec | D To issuer | 2012-01-31 | 2012-02-01 | 1,739 | — | $0 | 0 | SEC↗ |
| Wales Dirk O | SVP ? Chief Medical Officer | D To issuer | 2012-01-31 | 2012-02-01 | 1,332 | — | $0 | 0 | SEC↗ |
| Wales Dirk O | SVP ? Chief Medical Officer | D To issuer | 2012-01-31 | 2012-02-01 | 38,845 | — | $0 | 9,960 | SEC↗ |
| Wales Dirk O | SVP ? Chief Medical Officer | D To issuer | 2012-01-31 | 2012-02-01 | 485 | — | $0 | 0 | SEC↗ |
| Wales Dirk O | SVP ? Chief Medical Officer | D To issuer | 2012-01-31 | 2012-02-01 | 2,653 | — | $0 | 0 | SEC↗ |
| Wales Dirk O | SVP ? Chief Medical Officer | D To issuer | 2012-01-31 | 2012-02-01 | 4,121 | — | $0 | 0 | SEC↗ |
| Wales Dirk O | SVP ? Chief Medical Officer | D To issuer | 2012-01-31 | 2012-02-01 | 855 | — | $0 | 0 | SEC↗ |
| Wales Dirk O | SVP ? Chief Medical Officer | A Award | 2012-01-31 | 2012-02-01 | 855 | — | $0 | 855 | SEC↗ |
| Wales Dirk O | SVP ? Chief Medical Officer | D To issuer | 2012-01-31 | 2012-02-01 | 1,369 | — | $0 | 0 | SEC↗ |
| Fritch Herbert A | Chairman & CEO | D To issuer | 2012-01-31 | 2012-02-01 | 30,000 | — | $0 | 0 | SEC↗ |
| Fritch Herbert A | Chairman & CEO | D To issuer | 2012-01-31 | 2012-02-01 | 2,217,213 | — | $0 | 0 | SEC↗ |
| Barden J Gentry | Senior VP, Gen Counsel & Sec | G Gift | 2012-01-25 | 2012-02-01 | 1,200 | — | $0 | 38,461 | SEC↗ |
| Fritch Herbert A | Chairman & CEO | G Gift | 2012-01-25 | 2012-02-01 | 90,910 | — | $0 | 2,247,213 | SEC↗ |
| Mirt Michael G | President | A Award | 2012-01-18 | 2012-01-20 | 1,074 | $46.55 | $50.0K | 55,641 | SEC↗ |
| WITTY KAREY L | Exec VP and CFO | A Award | 2012-01-18 | 2012-01-20 | 2,148 | $46.55 | $100.0K | 41,752 | SEC↗ |
| Tulloch Mark A | EVP and COO | A Award | 2012-01-18 | 2012-01-20 | 306 | $46.55 | $14.2K | 53,493 | SEC↗ |
| Morris Matthew Shawn | EVP | A Award | 2012-01-18 | 2012-01-20 | 323 | $46.55 | $15.0K | 56,179 | SEC↗ |
| Hailey James R | SVP & Pres-Pharmacy Operatio | A Award | 2012-01-18 | 2012-01-20 | 2,148 | $46.55 | $100.0K | 21,446 | SEC↗ |
| Hailey James R | SVP & Pres-Pharmacy Operatio | A Award | 2012-01-18 | 2012-01-20 | 1,826 | — | $0 | 23,272 | SEC↗ |
| Wales Dirk O | SVP ? Chief Medical Officer | A Award | 2012-01-18 | 2012-01-20 | 1,369 | — | $0 | 48,805 | SEC↗ |